Invitae Corp NVTA:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:29 PM EST
2.44quote price arrow up+0.03 (+1.24%)
Volume
31,989
Close
2.41quote price arrow up+0.05 (+2.12%)
Volume
8,762,410
52 week range
1.67 - 12.04
Loading...
  • Open2.38
  • Day High2.44
  • Day Low2.28
  • Prev Close2.36
  • 52 Week High12.04
  • 52 Week High Date02/10/22
  • 52 Week Low1.67
  • 52 Week Low Date12/28/22

Key Stats

  • Market Cap585.39M
  • Shares Out242.90M
  • 10 Day Average Volume9.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.85
  • YTD % Change29.57

KEY STATS

  • Open2.38
  • Day High2.44
  • Day Low2.28
  • Prev Close2.36
  • 52 Week High12.04
  • 52 Week High Date02/10/22
  • 52 Week Low1.67
  • 52 Week Low Date12/28/22
  • Market Cap585.39M
  • Shares Out242.90M
  • 10 Day Average Volume9.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.85
  • YTD % Change29.57

RATIOS/PROFITABILITY

  • EPS (TTM)-13.84
  • P/E (TTM)-0.17
  • Fwd P/E (NTM)-1.43
  • EBITDA (TTM)-691.46M
  • ROE (TTM)-196.69%
  • Revenue (TTM)519.97M
  • Gross Margin (TTM)19.13%
  • Net Margin (TTM)-617.65%
  • Debt To Equity (MRQ)1,006.72%

EVENTS

  • Earnings Date02/22/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Invitae Corp

Content From Our Affiliates

Profile

MORE
Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services that support a lifetime of patient care from inherited disease diagnoses, to family planning, to proactive health screening to personalized diagnosis, treatment and monitoring of cancer. These tests are delivered through a platform that serves patients, healthcare providers, biopharma companies and other partners, thereby capturing the potential of genetics and...
Randal Scott Ph.D.
Chairman of the Board
Kenneth Knight
Chief Executive Officer
Yafei Wen
Chief Financial Officer
Robert Werner
Chief Accounting Officer
Address
1400 16Th Street
San Francisco, CA
94103
United States

Top Peers

SYMBOLLASTCHG%CHG
HLTH
Cue Health Inc
2.49-0.13-4.96%
ITOS
Iteos Therapeutics Inc
21.15+0.25+1.20%
RGNX
Regenxbio Inc
23.47+0.26+1.12%
ICPT
Intercept Pharmaceuticals Inc
18.76+0.50+2.74%
MOR
MorphoSys AG
5.06+0.11+2.22%